tirzepatide in Podcasts

powerful a medication compared to the higher doses of some of the injectable medications we have at the moment it has been studied in this attain maintain clinical trial looking at maybe people who are on the maximum tolerated dose of semidlutide which is ozentic wegovi or tirzepatide which is moonjarin shifting them then to the oral tablet and what they're seeing is maybe if people are on semidlutide they after a year they maintain most of the weight kind of reduction they've seen if people have been on moonjarin there is about a five kilo kind of weight reduction